##analysisDate=2017-06-28-12-43-17000
##analyzedBy=RingStudy Site E
##exportDate=2017-11-08-12-54-46000
##analysisName=Sample 5-PHASE1
##workflowName=Oncomine Focus w2.1 - DNA and Fusions - Single Sample
##sampleNames=Site E-R1-Sample 5-F-D_v1:Site E-R5-Sample 5-F-R_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Site D_NoRef
##searchText=
##chromosome=All
##totalVariantCount=833
##filterInCount=24
##filteredOutCount=809
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:65310517	C/CG	C	INDEL		JAK1	exonic	1					HS	COSM41751		CG=7.23, T=0.00	p.Arg724fs		1977	C=0.9277, CG=0.0723, T=0.0		Present				-	16	NM_002227.2	c.2170_2171insC	frameshiftInsertion	1.35				Protein kinase domain,Protein tyrosine kinase								ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	117.718	C=1834, CG=143, T=0		C=1139/695, CG=13/130, T=0/0	3,1	
chr1:65311214	G/C	G	SNV		JAK1	exonic	1								48.62	p.(=)		1997	G=0.5138, C=0.4862		Present				-	15	NM_002227.2	c.2097C>G	synonymous	2.86				Protein kinase domain,Protein tyrosine kinase	rs3737139		0.039 (ref)	0.0606	0.0111	0.0446	YES	ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	7332.6	G=1026, C=971		G=506/520, C=466/505	2	
chr1:115256530	GT/TT	GT	SNV		NRAS	exonic	1	Hotspot	Gain-of-function			HS	COSM581;COSM580;COSM12730		CT=0.00, TT=46.43, TA=0.00	p.Gln61Lys		1990	GT=0.5357, CT=0.0, TT=0.4643, TA=0.0		Present				-	3	NM_002524.4	c.181C>A	missense	2.62,0.35	0.01	53.0	0.948	Miro-like protein,Ras family	rs121913254							GTP binding,GTPase activity,Golgi apparatus,Golgi membrane,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,actin cytoskeleton organization,activation of MAPKK activity,axon guidance,blood coagulation,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane fraction,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of Rac protein signal transduction,positive regulation of cell proliferation,regulation of long-term neuronal synaptic plasticity,regulation of synaptic transmission, GABAergic,signal transduction,small GTPase mediated signal transduction,striated muscle cell differentiation,visual learning		untested	0.00001	7705.34	GT=1066, CT=0, TT=924, TA=0		GT=582/484, CT=0/0, TT=496/428, TA=0/0	1,1,1	
chr1:156834532, chr1:156851323			ASSAYS_5P_3P		NTRK1								NTRK1.5p.eNST00000392302.e2e3,NTRK1.3p.eNST00000392302.e17e18				0,542				NoCall	0.0015		0.0000,1.3557e-09																						0.0					
chr2:29416572	C/C	T	SNV		ALK	exonic	1								100.00	p.Ile1461Val		1986	T=0.0, C=1.0		Present				-	29	NM_004304.4	c.4381A>G	missense	-0.25	1.0	29.0	0.0	MAM domain,Protein kinase domain,Protein tyrosine kinase	rs1670283		0.007 (ref)	3.0E-4	0.0279	0.0097		ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	26678.2	T=0, C=1986		T=0/0, C=994/992	1	
chr2:29497967	G/A	G	SNV		ALK	exonic	1								45.67	p.Thr680Ile		1999	G=0.5433, A=0.4567		Present				-	11	NM_004304.4	c.2039C>T	missense	2.43	0.0	89.0	0.078	MAM domain,Protein kinase domain,Protein tyrosine kinase	rs35228363		0.01 (ref)	0.0291	0.0052	0.021	YES	ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	6582.7	G=1086, A=913		G=546/540, A=483/430	1	
chr2:29551347, chr2:29430138			ASSAYS_5P_3P		ALK								ALK.5p_NM_004304.4.e5e6,ALK.3p_NM_004304.4.e23e24				44648,972				Absent, LOW_5P_3P_IMBALANCE_SCORE	-0.1245		1.1168e-07,2.4313e-09																						0.0					
chr2:209113192	G/A	G	SNV		IDH1	exonic	1								46.30	p.(=)		2000	G=0.537, A=0.463		Present				-	4	NM_005896.3	c.315C>T	synonymous	1.35				Isocitrate/isopropylmalate dehydrogenase	rs11554137		0.049 (ref)	0.0531	0.106	0.071	YES	2-oxoglutarate metabolic process,NAD binding,NADPH regeneration,carbohydrate metabolic process,cellular lipid metabolic process,cytoplasm,cytosol,glutathione metabolic process,glyoxylate cycle,isocitrate dehydrogenase (NADP+) activity,isocitrate metabolic process,magnesium ion binding,mitochondrion,oxidoreductase activity,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,peroxisomal matrix,peroxisome,protein homodimerization activity,response to oxidative stress,tricarboxylic acid cycle	2'-Monophosphoadenosine 5'-Diphosphoribose,Isocitric Acid		0.00001	6745.66	G=1074, A=926		G=571/503, A=488/438	1	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100.00	p.(=)		1988	G=0.0, A=1.0		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7688609		0.042 (ref)	8.0E-4	0.131	0.0449	YES	ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	26746.3	G=0, A=1988		G=0/0, A=1135/853	1	
chr4:55141055	G/G	A	SNV		PDGFRA	exonic	1								100.00	p.(=)		1995	A=0.0, G=1.0		Present				+	12	NM_006206.4	c.1701A>G	synonymous	-5.31				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913270,rs121913271,rs1873778		0.037 (ref)	0.0015	0.1185	0.0411	YES	ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00001	26839.1	A=0, G=1995		A=0/0, G=1116/879	1	
chr4:55592166	T/TG	T	INDEL		KIT	exonic	1								17.67	p.Lys499fs		1981	T=0.8233, TG=0.1767		Present				+	9	NM_000222.2	c.1493_1494insG	frameshiftInsertion	1.07				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs67271072							ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00001	315.927	T=1631, TG=350		T=1012/619, TG=42/308	3	
chr4:55593625	ATGGAAACAATTATGTTTACATAGACC/ATGGAAACAATTATGTTTACATAGACCC	ATGGAAACAATTATGTTTACATAGACC	INDEL		KIT	exonic	1					HS	COSM22376		ATGGAAACAATTATGTTTACATAGACCC=5.78, CCT=0.00	p.Thr574fs		1903	ATGGAAACAATTATGTTTACATAGACC=0.9422, ATGGAAACAATTATGTTTACATAGACCC=0.0578, CCT=0.0		Present				+	11	NM_000222.2	c.1718_1719insC	frameshiftInsertion	2.32,0.2,2.88,2.88,-1.23,2.32,1.09,1.58,2.32,2.32,0.54,2.32,2.32,-0.26,2.88,2.32,-0.39,2.32,2.32,0.91,2.32,2.32,0.12,2.88,2.32,2.88,2.88				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs200945282							ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00002	46.042	ATGGAAACAATTATGTTTACATAGACC=1793, ATGGAAACAATTATGTTTACATAGACCC=110, CCT=0		ATGGAAACAATTATGTTTACATAGACC=840/953, ATGGAAACAATTATGTTTACATAGACCC=92/18, CCT=0/0	3,3	
chr4:55593686	T/TC	T	INDEL		KIT	exonic	1								12.10	p.Arg586fs		1984	T=0.879, TC=0.121		Present				+	11	NM_000222.2	c.1755_1756insC	frameshiftInsertion	0.2				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00001	98.6443	T=1744, TC=240		T=748/996, TC=179/61	3	
chr5:176517797	T/T	C	SNV		FGFR4	exonic	1								100.00	p.Pro136Leu		1992	C=0.0, T=1.0		Present				+	4	NM_213647.1	c.407C>T	missense	1.12	0.3	98.0	0.0	Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs376618		0.185 (ref)	0.248	0.3393	0.2789	YES	ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	26691.3	C=0, T=1992		C=0/0, T=1200/792	4	
chr5:176517985	A/G	A	SNV		FGFR4	exonic	1								23.30	p.(=)		1704	A=0.767, G=0.233		Present				+	5	NM_213647.1	c.483A>G	synonymous	-3.74				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	1621.29	A=1307, G=397		A=735/572, G=378/19	1	
chr6:117711009, chr6:117632280			ASSAYS_5P_3P		ROS1								ROS1.5p_NM_002944.2.e11e12,ROS1.3p_NM_002944.2.e38e39				43,0				Absent, LOW_5P_3P_IMBALANCE_SCORE	-1.0E-4		1.0756e-10,0.0000																						0.0					
chr7:55249063	A/A	G	SNV		EGFR,EGFR-AS1	exonic, exonic_nc	1								97.35	p.(=)		2000	G=0.0265, A=0.9735		Present				+, -	20	NM_005228.3, NR_047551.1	c.2361G>A	synonymous	2.8				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1050171		0.418 (ref)	0.3962	0.4226	0.4576	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	25261.9	G=53, A=1947		G=28/25, A=995/952	1	
chr7:55259514	CT/CTG	CT	INDEL		EGFR	exonic	1					HS	COSM12366;COSM24268;COSM13553		AA=0.00, AG=0.00, AT=0.00, CTG=9.79	p.Ala859fs		1971	CT=0.9021, AA=0.0, AG=0.0, AT=0.0, CTG=0.0979		Present				+	21	NM_005228.3	c.2575_2576insG	frameshiftInsertion	1.42,2.18				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs121434568,rs121913443							AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	283.224	CT=1778, AA=0, AG=0, AT=0, CTG=193		CT=907/871, AA=0/0, AG=0/0, AT=0/0, CTG=8/185	1,1,1,2	
chr8:38271504	A/AG	A	INDEL		FGFR1	exonic	1								21.96	p.Ser773fs		1985	A=0.7804, AG=0.2196		Present				-	18	NM_001174067.1	c.2316_2317insC	frameshiftInsertion	1.94				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,MAPKKK cascade,axon guidance,cell migration,chordate embryonic development,cytoplasm,cytoplasmic membrane-bounded vesicle,cytosol,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,heparin binding,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,neuron migration,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of neuron differentiation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of phospholipase activity,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell differentiation,regulation of transcription, DNA-dependent,skeletal system development,skeletal system morphogenesis	(E)-4-(3,5-difluorophenyl)-3H-pyrrolo2,3-bpyridin-3-ylidene(3-methoxyphenyl)methanol,3-(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE-2-INDOLINONE,3-(3-methoxybenzyl)-1H-pyrrolo2,3-bpyridine,Palifermin,SU4984		0.00001	729.911	A=1549, AG=436		A=883/666, AG=55/381	3	
chr10:43606730, chr10:43622086			ASSAYS_5P_3P		RET								RET.5p_NM_020975.4.e6e7,RET.3p_NM_020975.4.e18e19				405,2456				Absent, LOW_5P_3P_IMBALANCE_SCORE	0.0058		1.0130e-09,6.1433e-09																						0.0					
chr10:43613843	G/T	G	SNV		RET	exonic	1								48.40	p.(=)		1998	G=0.516, T=0.484		Present				+	13	NM_020975.4	c.2307G>T	synonymous	1.34				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	untested	0.00001	7278.2	G=1031, T=967		G=487/544, T=465/502	1	
chr10:43615607	T/TC	T	INDEL		RET	exonic	1								11.61	p.Arg897fs		1990	T=0.8839, TC=0.1161		Present				+	15	NM_020975.4	c.2689_2690insC	frameshiftInsertion	2.13				Cadherin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib		0.00001	53.9428	T=1759, TC=231		T=779/980, TC=205/26	3	
chr17:37881001	T/TG	T	INDEL		ERBB2	exonic	1					HS	COSM26681;COSM12555;COSM303939		TG=4.46, TGGG=0.00, TGGGCTCCCC=0.00, TGTGTGG=0.00	p.Ser779fs		1949	T=0.9554, TG=0.0446, TGGG=0.0, TGGGCTCCCC=0.0, TGTGTGG=0.0		Present				+	20	NM_004448.3	c.2333_2334insG	frameshiftInsertion	2.01				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain								ATP binding,ErbB-3 class receptor binding,Hsp90 protein binding,RNA polymerase I core binding,apical plasma membrane,axon guidance,basal plasma membrane,basolateral plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,cytoplasm,endosome membrane,enzyme linked receptor protein signaling pathway,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,estrus,glial cell differentiation,glycoprotein binding,growth factor binding,heart development,identical protein binding,integral to membrane,lateral loop,liver development,mammary gland development,mammary gland involution,membrane raft,microvillus,motor axon guidance,myelination,negative regulation of apoptotic process,negative regulation of immature T cell proliferation in thymus,nervous system development,neuromuscular junction development,nucleotide binding,nucleus,perinuclear region of cytoplasm,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of Ras protein signal transduction,positive regulation of cell adhesion,positive regulation of cell growth,positive regulation of epithelial cell proliferation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of transcription from RNA polymerase I promoter,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,postsynaptic membrane,protein C-terminus binding,protein autophosphorylation,protein binding,protein dimerization activity,protein heterodimerization activity,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,receptor complex,receptor signaling protein tyrosine kinase activity,regulation of ERK1 and ERK2 cascade,regulation of angiogenesis,regulation of microtubule-based process,regulation of transcription, DNA-dependent,response to axon injury,response to drug,response to progesterone stimulus,signal transduction,skeletal muscle tissue development,sympathetic nervous system development,tongue development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,transmembrane signaling receptor activity,ubiquitin protein ligase binding,wound healing	Lapatinib,Trastuzumab		0.02375	16.2436	T=1862, TG=87, TGGG=0, TGGGCTCCCC=0, TGTGTGG=0		T=901/961, TG=29/58, TGGG=0/0, TGGGCTCCCC=0/0, TGTGTGG=0/0	3,3,3,3	
chrX:70339233	C/T	C	SNV		MED12	exonic	1								57.44	p.Thr37Met		1908	C=0.4256, T=0.5744		Present				+	2	NM_005120.2	c.110C>T	missense	2.38	0.0	81.0	1.0		rs199469676,rs199469677,rs199469678,rs199469679,rs199469681							RNA polymerase II transcription cofactor activity,androgen receptor signaling pathway,beta-catenin binding,gene expression,intracellular steroid hormone receptor signaling pathway,ligand-dependent nuclear receptor transcription coactivator activity,mediator complex,negative regulation of Wnt receptor signaling pathway,nucleoplasm,nucleus,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein C-terminus binding,protein domain specific binding,receptor activity,thyroid hormone receptor binding,transcription coactivator activity,transcription cofactor activity,transcription initiation from RNA polymerase II promoter,vitamin D receptor binding			0.00001	9337.15	C=812, T=1096		C=362/450, T=499/597	1	
